Résumé
Background: To examine the stages of delay in presentation and management of oral cancer patients at University College Hospital Ibadan and compare findings with previous studies.
Methods: A 20-year retrospective analysis of the delay stages among oral cancer patients that utilized patient’s biodata and clinical data.
Result: 169 oral cancer cases consisting of 127 carcinomas, 25 sarcomas and 17 lymphomas were analyzed. There was significant difference in the mean evolution time (ET) according to histological type (oral carcinoma = 282.8±414, oral sarcomas = 219.2±247.3 and oral lymphomas 105.5±115 days; p = 0.001). Patient’s delay was more than professional delay for all cancer types (65.9%, 59.1% and 60.1% for carcinomas, sarcomas and lymphomas respectively). There was a significant difference in the mean ET of the early stage cancers compared with the late stage cancers (mean = 137.2±99 and 266.4±355; p = 0.010).
Conclusion: A combination of patients and professional delay negatively influenced the management of oral cancer patients but the patient’s delay formed the bulk of this combination in our center.
Keywords: Oral cancer, delay, management
Résumé
Contexte: Examiner les étapes du retard dans la présentation et le traitement des patients atteints de cancer de bouche au centre hospitalier universitaire d’Ibadan et comparer les résultats des études précédentes.
Méthodes: Une rétrospective des analyses de plus 20 années passées des étages du retard chez les patients atteints du cancer de bouche en à l’aide des données biographiques du patient et celles des cliniques.
Résultat: 169 cas de cancer de la bouche constitués de carcinomes (127), sarcomes (25) et 17 lymphomes ont été diagnostiqués. Il y avait d’importante différence dans la durée de l’évolution moyenne (EM) selon le type histologique (carcinome oral = 282,8 ± 414, les sarcomes orales = 219,2 ± 247,3 et 105,5 ± lymphomes orales 115 jours, p = 0,001). Le retard des patients était plus important que celui des professionnels pour tous les types de cancer (65,9%, 59,1% et 60,1% pour les carcinomes, les sarcomes et lymphomes respectivement). Il y avait également une importante différence dans la durée moyenne d’évaluation des cancers à un stade précoce par rapport aux cancers à un stade avancé (moyenne = 137,2 ± 99 et ± 355 266,4; p = 0,010).
Conclusion: La combinaison du retard des patients et celui des professionnels a influencé négativement la gestion des patients atteints de cancer de bouche mais le retard du patient reste la cause majeure de cette combinaison dans notre centre.
Correspondence: Dr. Akinyele Adisa, Department of Oral Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria. E-mail: perakin80@hotmail.com
Références
Warnakulasuriya KA. Oral cancer screening: 5 minutes to save a life. Lancet 2005; 365: 1905.
Morelatto RA, Herrera MC, Fernández EN, Corball AG, et al. Diagnostic delay of oral squamous cell carcinoma in two diagnosis centers in Córdoba Argentina. J Oral Pathol Med. 2007; 36(7):405-408.
Donnell A, Jin S and Zavras AI. Delay in the diagnosis of oral cancer J Stomatol Invest 2008; 2:15-26.
Van der Waal I, de Bree R, Brakenhoff R, et al. Early diagnosis in primary oral cancer: is it possible? Med Oral Patol Oral Cir Bucal. 2011; 16 (3):300-305.
Oji. C. Late presentation of orofacial tumors. J Cranio-Maxillofac Surg. 1999; 27:94-99.
Onyango JF and Macharia IM. Delays in diagnosis, referral and management of head and neck cancer presenting at Kenyatta national hospital, Nairobi. East Afr Med Journal. 2006; 83: (4) 85 – 91.
Otoh EC, Mandong BM, Danfillo IS, et al. Salivary gland tumors: A 16-year review at Jos University Teaching Hospital, Jos. Nig J Clin Biomed Res. 2006; 1: 51 - 57
Hirota SK, Braga PF, Penha SS, et al. Risk factors for oral squamous cell carcinoma in young and older Brazilian patients: A comparative analysis. Med Oral Patol Oral Cir Bucal. 2008; 13(4): 227-231.
Gaitán-Cepeda LA, Peniche-Becerra AG and Quezada-Rivera D. Trends in frequency and prevalence of oral cancer and oral squamous cell carcinoma in Mexicans: A 20 years retrospective study. Med Oral Patol Oral Cir Bucal. 2011; 16 (1):1-5.
Khandekar SP, Bagdey PS and Tiwari RR. Oral Cancer and Some Epidemiological Factors: A Hospital Based Study. Indian J Commun Med. 2006; 31: (3) 157 – 166.
Sugarman PB and Salvage NW. Oral cancer in Australia: 1983-1996. Austral Dent J. 2002; 47:(1):45-56
Howell RE, Wright BA and Dewar R. Trends in the incidence of oral cancer in Nova Scotia from 1983–1997. Oral Surg Oral Med Oral Pathol. 2003; 95:205–212.
Oliveira dos Santos LC, Cangussu MC, Olivier de Medeiros OM, et al. Oral Cancer: Population Sample of the State of Alagoas at a Reference Hospital. Braz J Otorhinolaryngol. 2009; 75(4):524-539.
Kayembe MK and Kalengayi MMR. Histological and epidemiological profile of oral cancer in Congo (Zaire). Odonto-stomatologie Tropicale. 1999; 22 (88): 29– 34.
Adisa AO, Oluwasola AO, Adeyemi BF, et al. Immunohistochemical analysis of undifferentiated and poorly-differentiated head and neck malignancies at a tertiary hospital in Nigeria. Head Neck Oncol 2010, 2:33.
Kerdpon D, Sriplung H. Factors related to advanced stage oral squamous cell carcinoma in southern Thailand. Oral Oncol 2001; 37:216-221.
Hollows P, McAndrew PG and Perini MG. Delays in the referral and treatment of oral squamous cell carcinoma. Br Dent J 2000; 188:262-265.
Tromp DM, Brouha XD, Hordijk GJ, et al. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract. 2005; 22:554-559.
Onizawa K, Nishihara K, Yamagata K, Yusa H, et al. Factors associated with diagnostic delay of oral squamous cell carcinoma Oral Oncol 2003; 39:781–788.
Warnakulasuriya S, Mak V and Moller H. Oral cancer survival in young people in South East England. Oral Oncol 2007; 43:982– 986.
Onyago JF and Machara I. delay in diagnosis, referral and management of head and neck cancers presenting in Kenyatta national hospital, Nairobi. East Afr Med J 2006; 83: 85 – 91.
Van den Bosch C and Lloyd G. Chikungunya fever as a risk factor for endemic Burkitt’s lymphoma in Malawi. Trans R Soc Trop Med Hyg 2000; 94:704–705.
Kumar S, Heller RF, Pandey U, et al. Delay in presentation of oral cancer: a multifactor analytical study. Natl Med J India 2001; 14:13-17.
Pitiphat W, Diehl SR, Laskaris G, et al. Factors associated with delay in the diagnosis of oral cancer. J Dent Res 2002; 81:192-197.
Brouha XD, Tromp DM, Hordijk GJ, et al. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck 2005; 27:939-945.
Allison P, Franco E, Black M, et al. The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma. Oral Oncol 1998; 34:147-153.
Sharp L, Lewin F, Hellborg H, et al. When does my treatment start? The continuum of care for patients with head and neck cancer. Radiother Oncol. 2002; 63:293-297.
Peacock ZS, Pogrel MA and Schmidt BL. Exploring the reasons for delay in treatment of oral cancer. J Am Dent Assoc. 2008; 139:1346-1352.
Scully C, Malamos D, Levers BG, et al. Sources and patterns of referrals of oral cancer: role of general practitioners. Br Med J 1986; 293:599-601.
Solanke TF. Cancer in Nigerian setting. Archives of Ibadan medicine 2000; 1: 3-5.